Hematology/Oncology

Top Story

FDA approves Piqray, first PI3K inhibitor for advanced breast cancer

May 24, 2019
FDA News

FDA approves Jakafi for acute graft-versus-host disease

May 24, 2019
The FDA approved ruxolitinib for the treatment of steroid-refractory acute graft-versus-host disease among adults and children aged 12 years and older. Ruxolitinib…
Meeting NewsVideo

VIDEO: Stool-based colon cancer tests may be effective between scheduled colonoscopies

May 24, 2019
SAN DIEGO — In this exclusive video from Digestive Disease Week, John B. Kisiel, MD, a gastroenterologist at the Mayo Clinic, discusses the results of two studies…
Meeting NewsVideo

VIDEO: Novel DNA markers accurately detect pancreatic cancer across all stages

May 24, 2019
SAN DIEGO — In this video from Digestive Disease Week, Shounak Majumder, MD, a gastroenterologist at the Mayo Clinic, discusses the results of a study that…
Feature

AI has potential to disrupt and transform cancer care, center director says

May 24, 2019
Translating genomic and big data into clinical tools for physicians and patients with cancer is an enormous challenge that has been enthusiastically accepted by Aziz
More Headlines »
CME

Decisions, Decisions: Differentiating Checkpoint Inhibitors for Bladder Cancer

This activity is supported by an educational grant from Merck & Co., Inc.

The integration of immune checkpoint inhibitors into treatment algorithms for patients with bladder cancer who have…
More »
Video
Meeting News

VIDEO: Transparency improves patient care, builds just culture

April 17, 2019
More »
Resource Centers
HemOnc Today New York

HemOnc Today New York

CME

Acute Lymphoblastic Leukemia Posters and Abstracts from San Diego

This activity is supported by educational funding provided by Amgen.

In this CME activity Elias Jabbour, MD, provides his perspectives on key posters presented at the American Society of…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next